| Business Summary | | Merck
&
Co.,
Inc.
is
a
global
research-driven
pharmaceutical
company
that
discovers,
develops,
manufactures
and
markets
a
broad
range
of
human
and
animal
health
products,
directly
and
through
its
joint
ventures,
and
provides
pharmaceutical
benefit
services
through
Merck-Medco
Managed
Care,
L.L.C.
(Merck-Medco).
The
Company's
operations
are
principally
managed
on
a
products
and
services
basis
and
are
comprised
of
two
reportable
segments,
Merck
Pharmaceutical,
which
includes
products
marketed
either
directly
or
through
joint
ventures,
and
Merck-Medco.
Merck
Pharmaceutical
products
consist
of
therapeutic
agents,
sold
by
prescription,
for
the
treatment
of
human
disorders.
Merck-Medco
revenues
are
derived
from
the
filling
and
management
of
prescriptions
and
health
management
programs. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Merck
and
Co.,
Inc.
is
a
pharmaceutical
company
that
discovers,
develops,
produces
and
markets
human/animal
health
products
and
services.
Merck
also
provides
pharmaceutical
benefit
services.
For
the
six
months
ended
6/30/01,
sales
rose
27%
to
$23.24
billion.
Net
income
rose
8%
to
$3.47
billion.
Results
reflect
strong
growth
in
worldwide
human
health
sales,
and
other
newer
and
established
products,
partially
offset
by
higher
materials
and
production
costs. | More
from
Market Guide: Significant
Developments |
| | | | FY2000
Compensation | | Pay | Exer | |
| Raymond Gilmartin, 60 Chairman,
Pres, CEO | $3.0M | -- | Judy Lewent, 52 CFO,
Exec. VP | 1.1M | $3.8M | David Anstice, 52 Pres,
The Americas and U.S. Human Health | 1.1M | 18.5M | Paul Bell, 55 Pres
of Human Health-Asia Pacific | -- | -- | Richard Clark, 55 Pres,
Merck-Medco Managed Care, L.L.C. | -- | -- | Dollar
amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|